Gelest Launches Vertasil® TM-CBD1, A Unique Hybrid Fluid Based on Cannabidiol (CBD)

Vertasil TM-CBD1 improves solubility with CBD in cosmetic ingredients, including silicones.

MORRISVILLE, Pa., Feb. 24, 2021 –Gelest, Inc. introduces Vertasil® TM-CBD1, a novel CBD hybrid fluid that that will increase formulation opportunities for personal care.

“We specifically designed this patented molecule to extend solubility parameters and improve the compatibility of CBD with a wider range of materials without compromising CBD activity or benefits,” said Daria Long, Gelest vice president and general manager, personal care. “The emollience of this modified CBD combined with the ability to form thin films enables distribution over skin and hair, providing effective treatments at extremely low concentrations.”

“Vertasil TM-CBD1 – the trisiloxane functionalized cannabidiol isolate – can be easily incorporated into silicone gel matrices such as polydimethylsiloxane (PDMS) and other primarily silicone-based formulations,” Long added. “In fact, Vertasil TM-CBD1 is the only ingredient that enables the delivery of Canabidiol from PDMS gels.” As an added benefit, it offers the potential for controlled release of CBD.

The newest product in Gelest’s Vertasil line of siloxane “tipped” natural products, Vertasil TM-CBD1 provides the lubricity and softness of a silicone oil without the greasiness of natural oils. Uniquely compatible with silicones in addition to natural oils, hydrocarbons, esters, glycols and silicone derivatives, Vertasil TM-CBD1 is targeted for use in silicone serums and oils; silicone, scar treatment and stretch-mark patches; and face and eye treatment masks. The ability of this hybrid fluid to generate effect at low concentrations offers economic advantages compared to pure CBD.

For more information or to obtain a Vertasil TM-CBD1 sample, contact Daria Long or Brett Ferguson at 215-547-1015.

About Gelest:

Gelest, headquartered in Morrisville, Pennsylvania, is an innovator, manufacturer, and supplier of silicones, organosilanes, metal-organics, and specialty monomers for advanced technology end markets including medical devices, life sciences, microelectronics, and personal care. Gelest, Inc. helps customers succeed by assisting them to develop and supply the chemistry to solve their most challenging materials science problems and to enable their new product technology.

For more information, please visit;


Media contact:

Mike Rubin


© 2023 Mitsubishi Chemical Group